Article Text

Download PDFPDF
Treating multivessel disease in the era of coated stents: introduction
  1. C Di Mario,
  2. G Mikhail
  1. Royal Brompton & Harefield NHS Trust, London, UK
  1. Correspondence to:
    Professor Carlo di Mario
    Royal Brompton & Harefield NHS Trust, Sydney Street, London SW3 6NP, UK;

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Numerous reports in cardiology congresses and journals deal with multivessel treatment with percutaneous transluminal coronary angioplasty (PTCA) and stenting. Clinical practice, however, is very different with more than 90% of all percutaneous revascularisation procedures in Europe and the USA limited to single vessel treatment. Even when performed in patients with multivessel disease, PTCA is often only performed in one vessel. In unstable syndromes intervention may be limited to the treatment of the culprit lesion and the more complete surgical or percutaneous …

View Full Text